Can FeNO be a biomarker in the post-COVID-19 patients monitoring?

The nature of the inflammatory and fibrotic processes found in patients with post-COVID-19 syndrome makes it possible to speculate that in such patients fractional exhaled nitric oxide (FeNO) may be a useful biomarker. Consequently, we set out to verify the consistency of this hypothesis. We consecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniscalco, Mauro, Ambrosino, Pasquale, Poto, Remo, Fuschillo, Salvatore, Poto, Sergio, Matera, Maria Gabriella, Cazzola, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789557/
https://www.ncbi.nlm.nih.gov/pubmed/35114576
http://dx.doi.org/10.1016/j.rmed.2022.106745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789557/
https://www.ncbi.nlm.nih.gov/pubmed/35114576
http://dx.doi.org/10.1016/j.rmed.2022.106745

Ejemplares similares